BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 16537974)

  • 1. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.
    Brand S; Beigel F; Olszak T; Zitzmann K; Eichhorst ST; Otte JM; Diepolder H; Marquardt A; Jagla W; Popp A; Leclair S; Herrmann K; Seiderer J; Ochsenkühn T; Göke B; Auernhammer CJ; Dambacher J
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G827-38. PubMed ID: 16537974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.
    Dambacher J; Beigel F; Seiderer J; Haller D; Göke B; Auernhammer CJ; Brand S
    Gut; 2007 Sep; 56(9):1257-65. PubMed ID: 17449633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
    Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
    J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.
    Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D
    Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
    Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
    Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R
    Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
    Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F
    J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
    Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
    Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF164) ameliorates intestinal epithelial injury in vitro in IEC-18 and Caco-2 monolayers via induction of TGF-beta release from epithelial cells.
    Bulut K; Pennartz C; Felderbauer P; Ansorge N; Banasch M; Schmitz F; Schmidt WE; Hoffmann P
    Scand J Gastroenterol; 2006 Jun; 41(6):687-92. PubMed ID: 16716967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
    Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
    Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration.
    Cesaro A; Brest P; Hofman V; Hébuterne X; Wildman S; Ferrua B; Marchetti S; Doglio A; Vouret-Craviari V; Galland F; Naquet P; Mograbi B; Unwin R; Hofman P
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G32-42. PubMed ID: 20185692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
    Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
    Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
    Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.